NEJM Journal Watch - General Medicine

Dr. Paul Sax shares a conversation held during IDWeek, in HIV and ID Observations.

In a randomized trial, a dedicated lifestyle clinic improved patients' risk factors and lowered recurrence of atrial fibrillation.

In a large series of patients with PCR-confirmed Oropouche fever, the disease was mostly mild, with a hospitalization rate of 2%.

A randomized trial finds no evidence for clinical benefit.

Low-quality evidence suggests a modest benefit.

Both strategies yielded similar postoperative outcomes.

In a randomized trial, patients who stopped their β-blockers were slightly more likely to be hospitalized for cardiovascular reasons.

Not according to a randomized trial of supplemental oxygen for patients with severe resting hypoxemia.

Metered-dose inhalers have carbon footprints that are 20 to 30 times larger than those of dry-powder inhalers.

In 15-year follow-up from a randomized trial, outcomes favored surgery over a nonoperative approach.